-
1.发明公开PHARMACEUTICAL COMPOSITION COMPRISING AMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 有权WITH A的酰胺衍生物或其药学上可接受的盐的药物组合物
公开(公告)号：EP2580206A2
公开(公告)日：2013-04-17
申请号：EP11792704.6
申请日：2011-06-10
发明人： KIM, Yong Il , KIM, Kyeong Soo , JANG, Ki Young , KIM, Yo Han , PARK, Jae Hyun , WOO, Jong Soo
IPC分类号： C07D401/12 , C07D401/14 , A61K31/497 , A61P35/00
CPC分类号： A61K47/24 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2077 , A61K9/4858 , A61K31/497 , A61K31/517 , A61K47/12 , C07D401/12 , C07D401/14
摘要： The present invention relates to a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof, and an acidic additive. This composition, owing to improved stability even after a long-term storage, is suitable for inhibiting the growth of cancer cells.
-
2.发明授权PHARMACEUTICAL COMPOSITION COMPRISING AMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 有权WITH A的酰胺衍生物或其药学上可接受的盐的药物组合物
公开(公告)号：EP2580206B1
公开(公告)日：2015-09-23
申请号：EP11792704.6
申请日：2011-06-10
发明人： KIM, Yong Il , KIM, Kyeong Soo , JANG, Ki Young , KIM, Yo Han , PARK, Jae Hyun , WOO, Jong Soo
IPC分类号： C07D401/12 , C07D401/14 , A61K31/497 , A61P35/00
CPC分类号： A61K47/24 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2077 , A61K9/4858 , A61K31/497 , A61K31/517 , A61K47/12 , C07D401/12 , C07D401/14
-
3.发明公开ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND AN ALKALIFYING AGENT 有权口服给药的药物组合物和非诺贝特碱化
公开(公告)号：EP2558077A2
公开(公告)日：2013-02-20
申请号：EP11769045.3
申请日：2011-04-12
发明人： JANG, Ki Young , PARK, Mijin , KIM, Kyeong Soo , KIM, Yong Il , PARK, Jae Hyun , WOO, Jong Soo
IPC分类号： A61K9/22 , A61K9/16 , A61K31/192
CPC分类号： A61K9/1611 , A61K9/1617 , A61K9/1623 , A61K9/1652 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K31/192
摘要： An oral pharmaceutical composition of the present invention comprising fenofibric acid or a pharmaceutically acceptable salt thereof, and 0.22 to 1 part by weight of an alkalifying agent based on 1 part by weight of fenofibric acid has improved bioavailability and a minimized absorption deviation in the gastrointestinal tract, which is useful in treating hyperlipidemia and hypertriglyceridemia.
-
4.发明授权ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND AN ALKALIFYING AGENT 有权口服VERABREICHTE PHARMAZEUTISCHE ZUSAMMENSETZUNG MITFENOFIBRINSÄUREUND EINEM ALKALISIERUNGSMITTEL
公开(公告)号：EP2558077B1
公开(公告)日：2017-03-01
申请号：EP11769045.3
申请日：2011-04-12
发明人： JANG, Ki Young , PARK, Mijin , KIM, Kyeong Soo , KIM, Yong Il , PARK, Jae Hyun , WOO, Jong Soo
IPC分类号： A61K9/22 , A61K9/16 , A61K9/50 , A61K31/192
CPC分类号： A61K9/1611 , A61K9/1617 , A61K9/1623 , A61K9/1652 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K31/192
-
-
-
搜索结果
4 条记录 (耗时 0.009 秒)
